Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Balance, at start of period (in shares) at Feb. 01, 2020   63,922,000        
Balance, at start of period at Feb. 01, 2020 $ 406,302 $ 936 $ 215,207 $ 533,690 $ 0 $ (343,531)
Balance, at start of period, treasury stock (in shares) at Feb. 01, 2020           29,710,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (154,050)     (154,050)    
Exercise of stock options and restricted stock (in shares)   802,000       802,000
Exercise of stock options and restricted stock 0   (1,609) (7,659)   $ 9,268
Share-based compensation 2,502   2,502      
Repurchase of common stock (in shares)   268,000       268,000
Repurchase of common stock (540)         $ (540)
Balance, at end of period (in shares) at May. 02, 2020   64,456,000        
Balance, at end of period at May. 02, 2020 254,214 $ 936 216,100 371,981 0 $ (334,803)
Balance, at end of period, treasury stock (in shares) at May. 02, 2020           29,176,000
Balance, at start of period (in shares) at Feb. 01, 2020   63,922,000        
Balance, at start of period at Feb. 01, 2020 406,302 $ 936 215,207 533,690 0 $ (343,531)
Balance, at start of period, treasury stock (in shares) at Feb. 01, 2020           29,710,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (352,169)          
Repurchase of common stock (in shares) 0          
Balance, at end of period (in shares) at Oct. 31, 2020   64,905,000        
Balance, at end of period at Oct. 31, 2020 $ 60,820 $ 936 220,047 169,038 0 $ (329,201)
Balance, at end of period, treasury stock (in shares) at Oct. 31, 2020           28,727,000
Balance, at start of period (in shares) at May. 02, 2020   64,456,000        
Balance, at start of period at May. 02, 2020 254,214 $ 936 216,100 371,981 0 $ (334,803)
Balance, at start of period, treasury stock (in shares) at May. 02, 2020           29,176,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (107,770)     (107,770)    
Exercise of stock options and restricted stock (in shares)   386,000       386,000
Exercise of stock options and restricted stock 0   (732) (3,682)   $ 4,414
Share-based compensation 2,460   2,460      
Repurchase of common stock (in shares)   12,000       12,000
Repurchase of common stock (28)         $ (28)
Balance, at end of period (in shares) at Aug. 01, 2020   64,830,000        
Balance, at end of period at Aug. 01, 2020 148,876 $ 936 217,828 260,529 0 $ (330,417)
Balance, at end of period, treasury stock (in shares) at Aug. 01, 2020           28,802,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (90,349)     (90,349)    
Exercise of stock options and restricted stock (in shares)   109,000       109,000
Exercise of stock options and restricted stock 0   (105) (1,142)   $ 1,247
Share-based compensation $ 2,324   2,324      
Repurchase of common stock (in shares) 0 34,000       34,000
Repurchase of common stock $ (31)         $ (31)
Balance, at end of period (in shares) at Oct. 31, 2020   64,905,000        
Balance, at end of period at Oct. 31, 2020 $ 60,820 $ 936 220,047 169,038 0 $ (329,201)
Balance, at end of period, treasury stock (in shares) at Oct. 31, 2020           28,727,000
Balance, at start of period (in shares) at Jan. 30, 2021 64,971,000 64,971,000        
Balance, at start of period at Jan. 30, 2021 $ 9,689 $ 936 222,141 114,732 0 $ (328,120)
Balance, at start of period, treasury stock (in shares) at Jan. 30, 2021 28,661,000         28,661,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (45,724)     (45,724)    
Exercise of stock options and restricted stock (in shares)   1,934,000       1,934,000
Exercise of stock options and restricted stock 0   (6,477) (15,659)   $ 22,136
Share-based compensation 2,523   2,523      
Repurchase of common stock (in shares)   647,000       647,000
Repurchase of common stock (2,167)         $ (2,167)
Balance, at end of period (in shares) at May. 01, 2021   66,258,000        
Balance, at end of period at May. 01, 2021 $ (35,679) $ 936 218,187 53,349 0 $ (308,151)
Balance, at end of period, treasury stock (in shares) at May. 01, 2021           27,374,000
Balance, at start of period (in shares) at Jan. 30, 2021 64,971,000 64,971,000        
Balance, at start of period at Jan. 30, 2021 $ 9,689 $ 936 222,141 114,732 0 $ (328,120)
Balance, at start of period, treasury stock (in shares) at Jan. 30, 2021 28,661,000         28,661,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (21,999)          
Repurchase of common stock (in shares) 0          
Balance, at end of period (in shares) at Oct. 30, 2021 67,050,000 67,050,000        
Balance, at end of period at Oct. 30, 2021 $ (8,169) $ 936 218,239 69,789 0 $ (297,133)
Balance, at end of period, treasury stock (in shares) at Oct. 30, 2021 26,582,000         26,582,000
Balance, at start of period (in shares) at May. 01, 2021   66,258,000        
Balance, at start of period at May. 01, 2021 $ (35,679) $ 936 218,187 53,349 0 $ (308,151)
Balance, at start of period, treasury stock (in shares) at May. 01, 2021           27,374,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 10,639     10,639    
Exercise of stock options and restricted stock (in shares)   998,000       998,000
Exercise of stock options and restricted stock 0   (4,659) (6,566)   $ 11,225
Share-based compensation 2,881   2,881      
Repurchase of common stock (in shares)   284,000       284,000
Repurchase of common stock (1,335)         $ (1,335)
Balance, at end of period (in shares) at Jul. 31, 2021   66,972,000        
Balance, at end of period at Jul. 31, 2021 (23,494) $ 936 216,409 57,422 0 $ (298,261)
Balance, at end of period, treasury stock (in shares) at Jul. 31, 2021           26,660,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 13,086     13,086    
Exercise of stock options and restricted stock (in shares)   119,000       119,000
Exercise of stock options and restricted stock 0   (622) (719)   $ 1,341
Share-based compensation $ 2,452   2,452      
Repurchase of common stock (in shares) 0 41,000       41,000
Repurchase of common stock $ (213)         $ (213)
Balance, at end of period (in shares) at Oct. 30, 2021 67,050,000 67,050,000        
Balance, at end of period at Oct. 30, 2021 $ (8,169) $ 936 $ 218,239 $ 69,789 $ 0 $ (297,133)
Balance, at end of period, treasury stock (in shares) at Oct. 30, 2021 26,582,000         26,582,000